In particular, immune microenvironment is also modulated by RTK and interestingly its inhibitors are less effective in patients with a tumor highly infiltrated by CD8+ lymphocytes and associated with a high level of programmed death-ligand 1 (PD-L1) (Matsumoto et al. 2019). The gene discussed is CD274; the disease is neoplasm.